Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Amplexd Therapeutics, Inc.

Clinical trials sponsored by Amplexd Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a vaginal suppository clear High-Risk HPV? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Could a vaginal suppository clear High-Risk HPV?

Disease control Recruiting now

This study tests whether a vaginal suppository called Dysplasix can help women clear high-risk human papillomavirus (HPV) and reverse low-grade cervical abnormalities. About 45 women with HPV and mild cervical changes will use the suppository or a placebo for 19 days. Researchers…

Phase 2 • Sponsor: Amplexd Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC